about
Use of Teriparatide to improve fracture healing: What is the evidence?Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in boneParathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathwayMultiple calcium channel transcripts in rat osteosarcoma cells: selective activation of alpha 1D isoform by parathyroid hormoneCurrent and potential future drug treatments for osteoporosis.Intermittent parathyroid hormone (PTH) promotes cementogenesis and alleviates the catabolic effects of mechanical strain in cementoblasts.Stemming bone loss by suppressing apoptosis.Modeling and remodeling effects of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone in a rat spinal fusion model.Update in new anabolic therapies for osteoporosisPrevention and treatment of multiple osteoporotic compression fractureIncreased bone formation by prevention of osteoblast apoptosis with parathyroid hormoneThe chloride/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individualsAmelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survivalInsulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormoneEvidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubThe calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.Role of teriparatide in treatment of glucocorticoid-induced osteoporosisUpdate on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosisAtherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats.A roadmap to the brittle bones of cystic fibrosis.Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.Gap junction intercellular communication: a review of a potential platform to modulate craniofacial tissue engineering.Urinary calcium and oxalate excretion in healthy adult cats are not affected by increasing dietary levels of bone meal in a canned diet.Anabolic agents and bone qualityStructural features of parathyroid hormone receptor coupled to Galpha(s)-protein.Spatial regulation of controlled bioactive factor delivery for bone tissue engineering.New concepts in calcium-sensing receptor pharmacology and signallingHypoxia-inducible factor-1α restricts the anabolic actions of parathyroid hormone.Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial.Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized ratsIntermittent administration of parathyroid hormone improves the repairing process of rat calvaria defects: A histomorphometric and radiodensitometric study.Osteoanabolics.Assessing adherence to teriparatide therapy, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture.Pulsatile release of parathyroid hormone from an implantable delivery system.Lasofoxifene (CP-336,156), a novel selective estrogen receptor modulator, in preclinical studies.Effect of TheraCyte-encapsulated parathyroid cells on lumbar fusion in a rat modelOverexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures
P2860
Q26801872-6C246BA7-4DD1-4300-B684-3E1A79B1A939Q27338722-5C5CD7A7-0177-47B6-B669-4905317A85BBQ28507612-EB67A33A-5EA6-4552-9BF2-44E396B403E4Q28567615-13EBF400-C778-41F2-8577-D689529833E0Q33579316-2A267C88-BD9C-49E5-8AFC-908DF6287C42Q33582160-5E96E7F1-7842-43A7-B976-E1A7763F305DQ33712675-C63CE45A-35FE-4185-AE6B-45CE24578A97Q33716899-2DA0F4B2-74BC-4AFF-8261-9E6FEACE8D7BQ33786824-5CE5797C-AA66-4F24-9081-CD33A41798C5Q33799411-85B5CC0E-C377-49C3-93D9-C639ACEB763CQ33857424-79862B22-2B25-45D3-A752-EF97C928E139Q33884904-A7B0CDFD-2D68-4EE9-8151-BD8AE92AFACBQ33910434-0FCFD547-4841-4C87-AB0F-1CE16C13A3B4Q33970422-7565F6A8-268B-4E66-95AF-15376BB8B72AQ34099162-3492BAF3-B82A-4FB9-9A6A-4F450C28A433Q34139850-9035EE3E-EB07-4C03-AE8A-E3E1288AD2E0Q34235921-E17ABB00-D005-4C00-884C-8573388190EDQ34271970-4FAF61CF-A876-430E-AAC9-0A08101E88FAQ34402832-4B3B9B74-7AC2-4430-9D91-94EC7585009EQ34418934-AD8B5F44-029E-4A9F-BA72-58535A5AB9ABQ34433399-4CC507C7-6E66-4D45-BA16-FD64C1D2A8A8Q34442832-6B8D42B5-B3B6-4BFC-A1EB-D25224235662Q34540003-A26AB65E-BF5A-4924-9990-D6C3F55232B1Q34778768-97FDCAC3-3B38-41B9-9B14-C84641FE39F2Q34935261-7B743B77-D2FC-4392-800E-04FFB469D5ECQ35078764-1A9575BB-3339-4ACA-8F94-C9A6F5E2800DQ35545546-A2A9E674-42A0-4C78-BFD6-72C415414DD4Q35598154-07D880BD-3461-4644-9E12-356CB4E1AC2BQ35657894-29C3A24E-BA56-4D01-81C7-49233785F7A5Q35755184-7B87AEA5-E971-41BB-B8CA-CB46F4E8DCB5Q35757224-6B5B221D-A7C2-4A2D-8454-9CE991884A70Q35783581-84E2B4A7-7C97-4DC0-9ED6-F6AB52690AD8Q35836995-87080CDA-4634-4EB3-B9E3-1B603E19773DQ35911548-DA4A22BD-9172-4D7F-B1E0-18280AB9592DQ35967742-4B118FEE-804A-4369-8B78-24D4A2891B38Q36056911-C7D4B7C3-080E-4E71-8F89-846847F72DC0Q36102547-D3E4E779-C82F-4443-855C-E5ACF881B4B6Q36271670-89720FE3-05A5-4615-8574-B20FD8A529E0Q36282080-937E0D1C-354C-4E92-BACF-E24530FAD776Q36293998-1A9F38BB-B8D3-4466-A6F2-6F83C750025B
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Anabolic actions of parathyroid hormone on bone.
@ast
Anabolic actions of parathyroid hormone on bone.
@en
Anabolic actions of parathyroid hormone on bone.
@nl
type
label
Anabolic actions of parathyroid hormone on bone.
@ast
Anabolic actions of parathyroid hormone on bone.
@en
Anabolic actions of parathyroid hormone on bone.
@nl
prefLabel
Anabolic actions of parathyroid hormone on bone.
@ast
Anabolic actions of parathyroid hormone on bone.
@en
Anabolic actions of parathyroid hormone on bone.
@nl
P2093
P356
P1433
P1476
Anabolic actions of parathyroid hormone on bone.
@en
P2093
P304
P356
10.1210/ER.14.6.690
P577
1993-12-01T00:00:00Z